𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Upregulation of Wilms’ tumour gene 1 (WT1) in uterine sarcomas

✍ Scribed by A. Coosemans; S. Amini Nik; S. Caluwaerts; S. Lambin; G. Verbist; R. Van Bree; V. Schelfhout; E. de Jonge; I. Dalle; G. Jacomen; J.J. Cassiman; Ph. Moerman; I. Vergote; F. Amant

Book ID
116429328
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
597 KB
Volume
43
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Wilms' tumour gene 1 (WT1) in human neop
Wilms' tumour gene 1 (WT1) in human neoplasia
✍ Keilholz, U; Menssen, H D; Gaiger, A; Menke, A; Oji, Y; Oka, Y; Scheibenbogen, C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB
Upregulation of Wilms' tumor gene 1 (WT1
Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors
✍ Saeid Amini Nik; Peter Hohenstein; Ali Jadidizadeh; Kim Van Dam; Adriana Bastida 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 287 KB

## Abstract Desmoid tumors (aggressive fibromatosis) are locally invasive soft tissue tumors in which β‐catenin/TCF3 mediated Wnt signaling is activated. More than 80% of desmoid tumors contain activating mutations in β‐catenin. It has been shown that the Wnt signaling pathway interacts with Wilms'

The clinical relevance of Wilms Tumour 1
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia
✍ Carolyn Owen; Jude Fitzgibbon; Peter Paschka 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Recurrent genetic aberrations are important predictors of outcome in acute myeloid leukaemia (AML). Numerous novel molecular abnormalities have been identified and investigated in recent years adding to the risk stratification and prognostication of conventional karyotyping. Mutations i